Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model Hung-Chuan Pan1–3, De-Wei Lai3, Keng-Hsin Lan4–6, Chin-Chang Shen7, Sheng-Mao Wu3, Chien-Shan Chiu3,8, Keh-Bin Wang9 and Meei-Ling Sheu3,10,*

1Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan, 2Department of Neurosurgery, Taichung Veterans General Hospital, Taichung 407, Taiwan, 3Institute of Biomedical Sciences, National Chung Hsing University, Taichung 402, Taiwan, 4Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan, 5Department and Institute of Pharmacology, National Yang-Ming University, Taipei 112, Taiwan, 6Department of Medicine, School of Medicine, School of Life Science, National Yang-Ming University, Taipei 112, Taiwan, 7Institute of Nuclear Energy Research, Atomic Energy Council, Longtan, Taoyuan 325, Taiwan, 8Department of Dermatology, Taichung Veterans General Hospital, Taichung 407, Taiwan, 9Department of Nuclear Medicine, Kuang Tien General Hospital, Taichung 433, Taiwan and 10Department of Education and Research, Taichung Veterans General Hospital, Taichung 407, Taiwan